LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA

Clinical trials for LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New scan could tell doctors which breast cancer drugs will work

Knowledge-focused Recruiting now

This study is testing whether a special type of PET scan can predict if a breast cancer drug called abemaciclib will work for patients with advanced hormone-positive, HER2-negative breast cancer. Researchers will give 60 participants this special scan before and after a brief hor…

Matched conditions: LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA

Phase: PHASE2 • Sponsor: University of Washington • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:35 UTC

LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA

Get alerted when new LOCALLY ADVANCED UNRESECTABLE HER2-NEGATIVE BREAST CARCINOMA trials appear

New scan could tell doctors which breast cancer drugs will work